Pharmacokinetics and Biotransformation

Correct Answer

A — Phenytoin

Rationale

Phenytoin is classified as exhibiting nonlinear (Michaelis-Menten) pharmacokinetics because the cytochrome P450 enzymes that metabolize it become saturated at concentrations within the therapeutic range. Once near saturation, elimination shifts from first-order toward zero-order kinetics, and a small dose increase produces a disproportionately large rise in steady-state plasma concentration. Digoxin, lithium, and vancomycin all have narrow therapeutic indexes and require monitoring, but their elimination follows first-order kinetics and dose-concentration relationships remain proportional at therapeutic concentrations.

Correct Answer

C — Vancomycin

Rationale

Vancomycin is now classified as best monitored using area under the curve to minimum inhibitory concentration ratio-guided dosing, with a target ratio of 400 to 600 milligram-hours per liter for serious infections. Current guidelines recommend this approach over simple trough monitoring because area under the curve better predicts both clinical efficacy and nephrotoxicity risk. Gentamicin is monitored by peak to minimum inhibitory concentration ratio, reflecting its concentration-dependent killing mechanism. Piperacillin-tazobactam is a time-dependent antibiotic; levels are not routinely monitored in standard practice. Azithromycin does not require therapeutic drug monitoring.

Correct Answer

B — Beta-lactam antibiotics

Rationale

Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) are classified as time-dependent killers whose bactericidal activity does not increase substantially above the minimum inhibitory concentration. The pharmacodynamic index that predicts clinical efficacy is the time that free drug concentration exceeds the minimum inhibitory concentration during the dosing interval, with targets of 40 to 70 percent depending on the specific drug and organism. Aminoglycosides and fluoroquinolones are concentration-dependent killers whose efficacy correlates with peak concentration to minimum inhibitory concentration ratio. Metronidazole exhibits mixed pharmacodynamic properties but is often classified with concentration-dependent or area under the curve-dependent agents.

Correct Answer

D — Aminoglycosides

Rationale

Aminoglycosides (gentamicin, tobramycin, amikacin) are classified as concentration-dependent killers whose bactericidal activity increases as drug concentration rises above the minimum inhibitory concentration. The pharmacodynamic index predicting clinical efficacy is the ratio of peak free drug concentration to minimum inhibitory concentration, with targets of 8 to 10 or greater. This classification is the pharmacodynamic basis for once-daily aminoglycoside dosing, which produces a higher peak than divided dosing of the same total daily dose. Penicillins and carbapenems are time-dependent killers. Glycopeptides such as vancomycin are area under the curve to minimum inhibitory concentration-dependent.

Correct Answer

A — Digoxin

Rationale

Digoxin is classified as requiring a 6 to 8 hour post-dose waiting period before sampling because it distributes extensively from plasma into cardiac and skeletal muscle during the distribution phase. A level drawn within the first few hours after a dose reflects the high plasma concentration during distribution and dramatically overestimates the equilibrium concentration that correlates with pharmacological effect. Lithium levels are drawn 12 hours after the last dose (trough). Phenobarbital has a long half-life and can be drawn as a trough; distribution phase is not a clinical concern. Vancomycin levels are drawn as trough or by area under the curve protocols but do not require the same post-dose waiting period as digoxin.

Correct Answer

C — Ethanol

Rationale

Ethanol is classified as undergoing zero-order elimination at all drinking concentrations because alcohol dehydrogenase is fully saturated at blood ethanol concentrations produced by even modest alcohol intake. The enzyme operates at its maximum rate regardless of blood ethanol concentration, eliminating approximately 7 to 10 grams of ethanol per hour in adults. As a result, blood ethanol concentration falls linearly over time rather than exponentially. Caffeine and acetaminophen at therapeutic doses follow first-order kinetics. Aspirin follows first-order kinetics at standard analgesic doses; saturable kinetics occur only at high anti-inflammatory doses.

Correct Answer

B — Drug Y will have a longer half-life because the larger volume of distribution means more drug must be cleared to halve the plasma concentration

Rationale

Half-life equals 0.693 multiplied by volume of distribution divided by clearance. When clearance is identical, the drug with the larger volume of distribution has the longer half-life. Drug Y has ten times the volume of distribution of Drug X, so its half-life will be ten times longer at the same clearance. The reason is that a larger volume of distribution means the drug is distributed more extensively into tissues; the plasma concentration at any given total body drug burden is lower, and it takes longer for clearance acting on plasma to remove half the total drug from the body. Amiodarone exemplifies this: its enormous volume of distribution produces a half-life of weeks despite reasonable hepatic clearance.

Correct Answer

D — Steady-state concentration will approximately double because steady-state concentration equals dose rate divided by clearance

Rationale

At steady state, the rate of drug input equals the rate of elimination. The average steady-state concentration equals the dose rate divided by clearance. When clearance falls by 50 percent and the dose rate is unchanged, the steady-state concentration must rise until a new equilibrium is reached — at which point the lower clearance acting on the higher concentration again eliminates drug at the rate it is being given. If clearance is halved, the new steady-state concentration will be approximately double the original. Volume of distribution does not affect steady-state concentration; it only affects the time needed to reach steady state. This relationship — steady-state concentration proportional to dose rate and inversely proportional to clearance — is the pharmacokinetic foundation for dose adjustment in organ impairment.

Correct Answer

A — Time to steady state is unchanged; steady state is always reached in approximately 5 half-lives regardless of dose

Rationale

The time to reach steady state is determined entirely by the elimination half-life and is independent of the dose, the dosing frequency, and the route of administration. Approximately 97 percent of the final steady-state concentration is achieved after 5 half-lives — for a drug with a 12-hour half-life, this is approximately 60 hours, regardless of whether the dose is 100 mg or 200 mg twice daily. Doubling the dose doubles the steady-state concentration that is eventually achieved, but does not change how long it takes to reach that new steady state. The only way to achieve a therapeutic concentration faster is to give a loading dose that immediately fills the volume of distribution.

Correct Answer

C — The metabolizing enzymes were near saturation at the original dose, so a small dose increase shifts elimination toward zero-order kinetics, producing a disproportionate concentration rise

Rationale

Phenytoin is metabolized by cytochrome P450 2C9 and cytochrome P450 2C19, which become substantially saturated at concentrations within the therapeutic range. At the original dose of 300 mg daily, the enzymes were operating near their maximum capacity. Adding 50 mg daily pushed the dose-concentration relationship into the near-zero-order region, where a small additional dose produces a much larger than proportional rise in steady-state concentration. This is the defining clinical consequence of Michaelis-Menten pharmacokinetics: the dose-concentration curve steepens sharply as saturation is approached. Phenytoin dose adjustments should be made in small increments of 25 to 50 mg, not 50 to 100 mg, precisely because of this nonlinearity.

Correct Answer

B — The loading dose fills the volume of distribution immediately, producing a therapeutic plasma concentration without waiting for accumulation over multiple half-lives

Rationale

When a drug has a long half-life, it takes many half-lives for the drug to accumulate to steady-state concentrations through maintenance dosing alone. A loading dose is calculated as the target plasma concentration multiplied by the volume of distribution, and when given as a single dose, immediately distributes throughout the body to fill the volume of distribution. The resulting plasma concentration approximates the target steady-state level right away. Maintenance dosing then replaces the drug eliminated between doses to sustain that concentration at steady state. The loading dose does not change clearance, half-life, or protein binding — it simply bypasses the accumulation process by placing the right total amount of drug in the body at the outset.

Correct Answer

D — The 24-hour interval will produce greater fluctuation because more drug is eliminated between doses, resulting in lower troughs and higher peaks

Rationale

At steady state, the peak-to-trough fluctuation within each dosing interval is determined by how much drug is eliminated between doses relative to the amount given. When the dosing interval is much longer than the half-life — as with a 24-hour interval for a drug with a 6-hour half-life — four half-lives elapse between doses, meaning approximately 94 percent of the dose is eliminated before the next dose. This produces very high peaks and very low troughs. With a 6-hour interval equal to one half-life, only 50 percent of the dose is eliminated between doses, producing much smaller peak-to-trough swings. For drugs with narrow therapeutic indexes, shorter dosing intervals relative to the half-life are chosen specifically to reduce fluctuation and keep concentrations within the therapeutic window throughout the dosing interval.

Correct Answer

A — Age-related reduction in muscle mass lowers creatinine production, so a normal serum creatinine underestimates the true reduction in renal clearance of digoxin

Rationale

Digoxin is eliminated almost entirely by renal excretion, so its clearance falls proportionally with glomerular filtration rate. Glomerular filtration rate declines with age even in the absence of recognized kidney disease. In elderly patients with reduced muscle mass, creatinine production falls proportionally to the fall in glomerular filtration rate, so serum creatinine remains in the normal reference range despite substantially reduced renal function. A serum creatinine of 1.1 milligrams per deciliter in an 80-year-old man weighing 60 kilograms may correspond to a glomerular filtration rate of only 30 to 40 milliliters per minute. Standard digoxin doses calculated for adults with normal renal function will accumulate in this patient, raising plasma levels into the toxic range. Digoxin does not undergo hepatic metabolism and does not exhibit nonlinear kinetics.

Correct Answer

C — Glomerular filtration rate increases substantially during pregnancy, accelerating renal clearance of lamotrigine and lowering plasma concentrations

Rationale

Pregnancy produces a 40 to 50 percent increase in blood volume and a 50 to 60 percent increase in glomerular filtration rate by the third trimester. Lamotrigine is eliminated primarily by renal excretion of its glucuronide conjugate. The pregnancy-related increase in glomerular filtration rate accelerates renal clearance of lamotrigine, lowering plasma concentrations at the same dose. This pharmacokinetic change is clinically important: lamotrigine levels can fall by 40 to 65 percent during pregnancy, often requiring dose increases of 50 percent or more to maintain seizure control. Levels should be monitored regularly during pregnancy and the dose reduced back toward the pre-pregnancy level after delivery as glomerular filtration rate returns to baseline within weeks.

Correct Answer

D — Phenytoin metabolizing enzymes were near saturation at the original dose, so a small dose increase shifted elimination toward zero-order kinetics and produced a disproportionate concentration rise

Rationale

Phenytoin exhibits Michaelis-Menten pharmacokinetics because cytochrome P450 2C9 and 2C19 become saturated at concentrations within the therapeutic range. At a level of 13 micrograms per milliliter, the enzymes were already operating near their maximum capacity. The additional 50 mg daily dose pushed the system past the saturation threshold, where elimination becomes zero-order — a fixed amount, rather than a fixed fraction, is eliminated per unit time. In this kinetic region, a small dose increment produces a steep, disproportionate rise in steady-state concentration. Phenytoin dose adjustments must be made in small increments of 25 to 50 mg, with adequate waiting time between adjustments, to avoid this toxicity pattern.

Correct Answer

B — The 2-hour sample was drawn during the distribution phase when digoxin had not yet equilibrated with tissues, producing a falsely elevated plasma level

Rationale

Digoxin distributes extensively into cardiac and skeletal muscle, a process that takes 6 to 8 hours to reach equilibrium after an intravenous dose. When a blood sample is drawn during the distribution phase, plasma concentrations are high relative to what they will be once the drug has distributed fully into tissues — the plasma is still delivering drug to the tissues, so plasma concentration is temporarily higher than the eventual equilibrium level. The 3.6 nanograms per milliliter level at 2 hours reflected this distribution phase and does not predict toxicity. The 1.1 nanograms per milliliter level at 8 hours represents the true equilibrium concentration that correlates with pharmacodynamic effect. Digoxin levels must always be drawn at least 6 to 8 hours after a dose to be interpretable.

Correct Answer

A — Pregnancy increases glomerular filtration rate, accelerating renal clearance of lamotrigine and lowering its plasma concentration

Rationale

Glomerular filtration rate increases 50 to 60 percent above baseline by the third trimester of pregnancy. Lamotrigine is eliminated primarily as a renal-excreted glucuronide conjugate, so increased glomerular filtration rate accelerates its total clearance and lowers steady-state plasma concentrations at an unchanged dose. Lamotrigine levels can fall by 40 to 65 percent during pregnancy, making breakthrough seizures a recognized risk. Dose increases guided by therapeutic drug monitoring are often required in the second and third trimesters, followed by dose reduction after delivery as glomerular filtration rate returns to the pre-pregnancy baseline within weeks.

Correct Answer

C — Extended infusion, because beta-lactams are time-dependent killers whose efficacy depends on maintaining drug concentration above the minimum inhibitory concentration for a greater proportion of the dosing interval

Rationale

Beta-lactam antibiotics are time-dependent killers: their bactericidal activity does not increase above the minimum inhibitory concentration and is maximized when free drug concentration remains above the minimum inhibitory concentration for 40 to 70 percent of the dosing interval. A 4-hour extended infusion of the same dose maintains drug concentration above the minimum inhibitory concentration for a longer proportion of the dosing interval than a 30-minute bolus, which produces a brief high peak followed by a longer period below target. At the same total daily dose, extended infusion is pharmacodynamically superior for time-dependent antibiotics against organisms with higher minimum inhibitory concentrations. The extended infusion does not increase the total area under the curve — that is determined by the dose and clearance alone — but it does reshape the concentration-time profile to better match the pharmacodynamic requirements of time-dependent killing.